Liberty Expedia Holdings (LEXEB:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 48.050000 57276969 None 1.0939 55.75 -28.30
LEXEA Liberty Expedia Holdings Inc 47.040000 57276969 None 1.0709 55.75 -28.30
SOHU Sohu.com Ltd 19.880000 38916788 None 1.1645 29.71 23.98
PDLI PDL BioPharma Inc 2.630000 145400381 3.6029 0.5366 2.72 1.89
NLNK NewLink Genetics Corp 2.390000 37214286 None 0.7118 3.68 3.68
FBIO Fortress Biotech Inc 1.600000 54342589 None 1.9792 1.81 0.27
OPHT Ophthotech Corp 2.360000 36198436 0.5540 4.8733 4.03 5.82
AQXP Aquinox Pharmaceuticals Inc 2.930000 23537368 None 0.7606 4.21 4.21
VBLT Vascular Biogenics Ltd 1.625000 35855461 None 0.9542 1.63 1.03
VSAR Versartis Inc 1.400000 36240673 None 0.7360 1.87 1.67
VVUS VIVUS Inc 4.410000 10622716 None None 5.38 -22.43
APWC Asia Pacific Wire & Cable Corp Ltd 2.700000 13819669 9.3103 0.2358 3.91 1.37
GIGM GigaMedia Ltd 2.930000 11052235 32.0000 0.5438 5.50 5.77
ASNS Arsanis Inc 1.620000 14315410 None 0.6141 3.49 2.71
VXRT Vaxart Inc 2.850000 7141189 None 0.9105 3.35 2.72
EPIX ESSA Pharma Inc 3.001000 5776098 None 1.5847 3.13 1.93
CYCC Cyclacel Pharmaceuticals Inc 1.370000 11997447 None 0.8825 1.65 0.96
ABAC Renmin Tianli Group Inc 2.020000 7983745 25.2500 0.1810 7.87 7.61
NVIV InVivo Therapeutics Holdings Corp 2.020000 7763420 None 1.8562 2.88 2.83
ACHV Achieve Life Sciences Inc 3.150000 4551005 0.0211 0.8719 3.36 0.92
RTTR Ritter Pharmaceuticals Inc 1.860000 5534639 None 0.9644 2.94 None
ATOS Atossa Genetics Inc 1.750000 5500000 None 0.7095 2.77 1.43
KBSF KBS Fashion Group Ltd 3.930000 2206741 None 0.1203 10.93 10.21
AYTU Aytu BioScience Inc 2.760000 1801411 None 0.3704 3.89 4.81
RLM Realm Therapeutics PLC 2.986900 4662476 None 0.5736 3.48 2.74

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

LEXEB:NAS Liberty Expedia Holdings

http://www.libertyexpedia.com
Liberty Expedia Holdings has 23101 employees and is headquartered in United States.
Liberty Expedia Holdings Inc is an online travel company. It operates a strong brand portfolio with global reach, targeting a broad range of travelers, travel suppliers, and advertisers.

OPHT:NAS Ophthotech

http://www.ophthotechinc.com
Ophthotech has 41 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate is called as Fovista.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.